Management of Targeted Drug Resistance in NSCLC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 24, doi. 10.1177/155989771403015
- By:
- Publication type:
- Article
Works matching IS 15598977 AND DT 2014 AND VI 14 AND IP 3
Results: 17
1
2
Experts Discuss the Promises and Challenges with Targeted Therapies.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 22, doi. 10.1177/155989771403014
- By:
- Publication type:
- Article
3
Targeted Therapies for NSCLC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 20, doi. 10.1177/155989771403013
- By:
- Publication type:
- Article
4
Current Approaches to Surgical Management of Lung Cancer.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 18, doi. 10.1177/155989771403012
- By:
- Publication type:
- Article
5
Immunotherapy for the Treatment of NSCLC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 29, doi. 10.1177/155989771403017
- By:
- Publication type:
- Article
6
Overview of Guideline Recommendations for Screening and Management of Lung Cancer.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 26, doi. 10.1177/155989771403016
- By:
- Publication type:
- Article
7
Stereotactic Body Radiation Therapy: Approaches in Early-Stage NSCLC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 17, doi. 10.1177/155989771403011
- By:
- Publication type:
- Article
8
Accelerated Sequential Radiotherapy and Survival in NSCLC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 15, doi. 10.1177/155989771403010
- By:
- Publication type:
- Article
9
Randomized, Prospective Trial of Customized Neoadjuvant versus Standard Chemotherapy Gets Underway.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 14, doi. 10.1177/155989771403009
- By:
- Publication type:
- Article
10
Progression-Free Survival Not Improved with Cabazitaxel versus Topotecan in Refractory SCLC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 13, doi. 10.1177/155989771403008
- By:
- Publication type:
- Article
11
Brain Metastases Safely Treated with WBRT after Bevacizumab and Chemotherapy in NSCLC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 12, doi. 10.1177/155989771403007
- By:
- Publication type:
- Article
12
Benefit and Tolerance to Induction Therapy in Elderly Patients with Locally Advanced NSCLC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 11, doi. 10.1177/155989771403006
- By:
- Publication type:
- Article
13
No Significant Difference in Treatment versus Supportive Care in Stage IV NSCLC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 10, doi. 10.1177/155989771403005
- By:
- Publication type:
- Article
14
Paclitaxel plus Bevacizumab is a Feasible Option for Chemoresistant SCLC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 9, doi. 10.1177/155989771403004
- By:
- Publication type:
- Article
15
Downregulation of ERCC1 Boosts Efficacy of Platinum-Based NSCLC Chemotherapy.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 8, doi. 10.1177/155989771403003
- By:
- Publication type:
- Article
16
Molecular Testing in Lung Cancer Pathology.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 6, doi. 10.1177/155989771403002
- By:
- Publication type:
- Article
17
Immunomodulation of Checkpoints Resets Immune System in NSCLC.
- Published in:
- MD Conference Express, 2014, v. 14, n. 3, p. 4, doi. 10.1177/155989771403001
- By:
- Publication type:
- Article